一项比较OKT3和类固醇治疗肝移植排斥反应的随机临床试验。 - Suppr | 超能文献

A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection.

作者信息

Cosimi A B, Cho S I, Delmonico F L, Kaplan M M, Rohrer R J, Jenkins R L

机构信息

Department of Surgery, Massachusetts General Hospital, Boston 02114.

出版信息

Transplant Proc. 1987 Feb;19(1 Pt 3):2431-3.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection.一项比较OKT3和类固醇治疗肝移植排斥反应的随机临床试验。

Transplant Proc. 1987 Feb;19(1 Pt 3):2431-3.

2

Single center randomized trial using ATG v OKT3 treatment in steroid resistant rejection crises after kidney transplantation.

Transplant Proc. 1989 Feb;21(1 Pt 2):1747.

3

Histologic response to OKT3 therapy for hepatic allograft rejection.肝移植排斥反应的OKT3治疗的组织学反应

Transplant Proc. 1987 Feb;19(1 Pt 3):2459-61.

4

OKT3 therapy for hepatic allograft rejection: comparison of results in adults and children.用于肝移植排斥反应的OKT3治疗：成人与儿童结果对比

Transplant Proc. 1990 Aug;22(4):1765-6.

5

Rescue of severe steroid-resistant rejection with OKT3.PAN.使用OKT3.PAN挽救严重的类固醇抵抗性排斥反应。

Transplant Proc. 1987 Feb;19(1 Pt 3):1908-9.

6

Immunohistology of liver allografts in recipients managed with prophylactic OKT3.接受预防性OKT3治疗的受体中肝脏同种异体移植物的免疫组织学

Transplant Proc. 1989 Feb;21(1 Pt 2):2249-50.

7

Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy.

Transplant Proc. 1987 Apr;19(2 Suppl 1):32-6.

8

Low serum OKT3 levels correlate with failure to prevent rejection in orthotopic liver transplant patients.血清OKT3水平低与原位肝移植患者预防排斥反应失败相关。

Transplant Proc. 1990 Aug;22(4):1774-6.

9

Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation.使用抗人T细胞单克隆抗体（Orthoclone OKT3）治疗急性肾移植排斥反应及作为肾移植的一线治疗方法。

Transplant Proc. 1988 Oct;20(5 Suppl 6):87-9.

10

Orthoclone OKT3 monoclonal antibody reversal of hepatic and cardiac allograft rejection unresponsive to conventional immunosuppressive treatments.

Transplant Proc. 1987 Apr;19(2 Suppl 1):54-7.

引用本文的文献

1

Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts.人源化、不结合Fc受体的抗CD3抗体hu12F6mu在肾移植受者中的I期试验。

MAbs. 2010 Jul-Aug;2(4):449-56. doi: 10.4161/mabs.12305. Epub 2010 Jul 1.

2

Effect of OKT3 on survival and rate of retransplantation.OKT3对生存率及再次移植率的影响。

Transplant Proc. 1987 Aug;19(4 Suppl 3):61-2.